Related Experiment Videos
3D ultrasound guided breast biopsy system
A Fenster1, K J M Surry, G R Mills
1Imaging Research Laboratory, Robarts Research Institute, P.O. Box 5015, 100 Perth Drive, London, Ont., Canada N6A 5K8. afenster@imaging.robarts.ca
Ultrasonics
|March 30, 2004
Summary
A new 3D ultrasound-guided biopsy system integrated with stereotactic mammography (SM) improves breast lesion targeting. This dual modality system enhances accuracy and success rates for biopsies, offering a more complete imaging solution.
Area of Science:
- Medical Imaging
- Biotechnology
- Radiology
Background:
- Stereotactic mammography (SM) and ultrasound (US) are standard breast biopsy techniques.
- Both SM and US have limitations, including procedure length, discomfort, and 2D imaging constraints.
- A need exists for improved accuracy and broader applicability in breast biopsy guidance.
Purpose of the Study:
- To develop and evaluate a novel 3D ultrasound-guided biopsy system integrated with stereotactic mammography.
- To combine the strengths of 3D US and SM for enhanced breast lesion targeting and biopsy.
- To improve the ability to biopsy a larger percentage of suspicious breast masses.
Main Methods:
- Development of a dual modality breast biopsy system integrating 3D US with SM.
- Utilizing breast phantoms to assess the system's targeting accuracy for artificial lesions.
- Employing metal beads for registration of SM geometry with 3D US images.
Main Results:
- The 3D US-guided biopsy system successfully targeted artificial lesions as small as 3.2 mm with a 96% success rate in phantoms.
- The system demonstrated performance equivalent to current clinical practice in in vitro biopsy tasks.
- Target registration error between SM and 3D US was measured at 1.6 mm, with vertical positioning error being the primary contributor.
Conclusions:
- The integrated 3D US and SM biopsy system offers a promising advancement in breast imaging and biopsy guidance.
- This dual modality approach enhances target identification, real-time monitoring, and confirmation of biopsy success.
- The system has the potential to increase the proportion of suspicious breast masses that can be successfully biopsied using ultrasound.